References
- National Institute on Drug Abuse. Overdose death rates; 2018. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Accessed October 8, 2018.
- Unick GJ, Ciccarone D. US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations. Int J Drug Policy. 2017;46:112–119.
- Gladden RM, Martinez P, Seth P. Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths—27 states, 2013–2014. Morb Mortal Wkly Rep. 2016;65:837–843.
- Pouget ER, Fong C, Rosenblum A. Racial/ethnic differences in prevalence trends for heroin use and non-medical use of prescription opioids among entrants to opioid treatment programs, 2005–2016. Subst Use Misuse. 2018;53(2):290–300.
- Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths – United States, 2010–2015. Morb Mortal Wkly Rep. 2016;65(50–51):1445–1452.
- Monnat SM, Rigg KK. The Opioid Crisis in Rural and Small Town America. Durham, NH: Carsey School of Public Policy; 2018.
- Rigg KK, Monnat SM, Chavez MN. Opioid-related mortality in rural America: geographic heterogeneity and intervention strategies. Int J Drug Policy. 2018;57:119–129.
- McBain RK, Rose AJ, LaRochelle MR. The U.S. opioid epidemic: one disease, diverging tales. Prev Med. 2018;112:176–178.
- Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182–186.
- Vivolo-Kantor AM, Seth P, Gladden RM, et al. Vital signs: trends in emergency department visits for suspected opioid overdoses – United States, July 2016–September 2017. Morb Mortal Wkly Rep. 2018;67(9):279.
- Mattson CL, O’Donnell J, Kariisa M, Seth P, Scholl L, Gladden RM. Opportunities to prevent overdose deaths involving prescription and illicit opioids, 11 states, July 2016–June 2017. Morb Mortal Wkly Rep. 2018;67(34):945.
- Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146–155.
- Wermeling DP. Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access. Therap Adv Drug Safety. 2015;6(1):20–31.
- Kinsman JM, Robinson K. National systematic legal review of state policies on emergency medical services licensure levels' authority to administer opioid antagonists. Prehosp Emerg Care. 2018;22(5):650–654.
- Davis CS, Southwell JK, Niehaus VR, Walley AY, Dailey MW. Emergency medical services naloxone access: a national systematic legal review. Acad Emerg Med. 2014;21(10):1173–1177.
- Faul M, Dailey MW, Sugerman DE, Sasser SM, Levy B, Paulozzi LJ. Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities. Am J Public Health. 2015;105(S3):e26.
- Mack KA, Jones CM, Ballesteros MF. Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas—United States. Am J Transplant. 2017;17(12):3241–3252.
- Hatten BW. Factors associated with prehospital naloxone use. Clin Toxicol. 2014;52(4):316–317.
- Faul M, Lurie P, Kinsman JM, Dailey MW, Crabaugh C, Sasser SM. Multiple naloxone administrations among emergency medical service providers is increasing. Prehosp Emerg Care 2017;21(4):411–419.
- Cash RE, Kinsman J, Crowe RP, Rivard MK, Faul M, Panchal AR. Naloxone administration frequency during emergency medical service events – United States, 2012–2016. Morb Mortal Wkly Rep. 2018;67(31):850–853.
- Stein BD, Dick AW, Sorbero M, et al. A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees. Subst Abus. 2018;39(4):419–425.
- Lambdin BH, Davis CS, Wheeler E, Tueller S, Kral AH. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States. Drug Alcohol Depend. 2018;188:370–376.
- Chapman SA, Crowe RP, Bentley MA. Recruitment and retention of new emergency medical technician (EMT) – basics and paramedics. Prehosp Disaster Med. 2016;31(S1):S70–S86.
- Mann NC, Kane L, Dai M, Jacobson K. Description of the 2012 NEMSIS public-release research dataset. Prehosp Emerg Care. 2015;19(2):232–240.
- Darke S, Mattick RP, Degenhardt L. The ratio of non-fatal to fatal heroin overdose. Addiction. 2003;98(8):1169–1171.
- Hedegaard H, Warner M, Miniño A. Drug overdose deaths in the United States, 1999–2016. Hyattsville, MD: National Center for Health Statistics; 2017.
- Ruhm CJ. Geographic variation in opioid and heroin involved drug poisoning mortality rates. Am J Prev Med. 2017;53(6):745–753.
- Ruhm CJ. Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999–2015. Addiction. 2018;113(7):1339–1344.
- U.S. Department of Agriculture. Urban influence codes. [Dataset]; 2013. https://www.ers.usda.gov/data-products/urban-influence-codes/. Accessed October 8, 2018.
- Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–179.
- Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137.
- Ray BR, Lowder EM, Kivisto AJ, Phalen P, Gil H. EMS naloxone administration as non‐fatal opioid overdose surveillance: 6‐year outcomes in Marion County, Indiana. Addiction. 2018;113(12):2271–2279.
- Olfson M, Wall M, Wang S, Crystal S, Blanco C. Risks of fatal opioid overdose during the first year following nonfatal overdose. Drug Alcohol Depend. 2018;190:112–119.
- Wolfram J. More Philly overdose patients turning down ambulance ride after naloxone; 2017. https://whyy.org/segments/philly-overdose-patients-turning-ambulance-ride-naloxone/. Accessed November 29, 2018.
- Gokavi M. Dayton police have revived one overdose patient 20 times; 2017. https://www.daytondailynews.com/news/crime–law/dayton-police-have-revived-one-overdose-patient-times/ZS7LRrdXlZ6K60sxlD61AO/. Accessed May 17, 2019.
- Narcan SC. It saves lives. Does it enable addicts? 2015. https://www.themarshallproject.org/2015/08/14/narcan-it-saves-lives-does-it-enable-addicts. Accessed May 17, 2019.
- Doleac J, Mukherjee A. The Moral Hazard of Lifesaving Innovations: Naloxone Access, Opioid Abuse, and Crime. Bonn, Germany: Institute for the Study of Labor (IZA); 2018. IZA discussion paper No. 11489.
- Russell A, Anderson K. Narcan saves lives, but with some unintended consequences; 2016. https://www.vpr.org/post/narcan-saves-lives-some-unintended-consequences#stream/0. Accessed May 17, 2019.
- Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP. Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Drug Alcohol Depend. 2019;200:34–39.
- Rose AJ, McBain R, Schuler MS, et al. Effect of age on opioid prescribing, overdose, and mortality in Massachusetts, 2011 to 2015. J Am Geriatr Soc. 2019;67(1):128–132.
- D’onofrio G, O’connor PG, Pantalon MV, et al. Emergency department–initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–1644.
- U.S. Census Bureau. State population totals and components of change: 2010–2016. [Dataset]; 2017. https://www.census.gov/data/tables/2016/demo/popest/state-total.html. Accessed July 23, 2018, 2018.
- Banta-Green CJ, Coffin PO, Schoeppe JA, Merrill JO, Whiteside LK, Ebersol AK. Heroin and pharmaceutical opioid overdose events: emergency medical response characteristics. Drug Alcohol Depend. 2017;178:1–6.